mutations and sophisticated kar yotype. It follows a linear evolution in the CLL clone with the recurrent acquisition of CDKN2A??? "???????????????????????????????????????????????").82,83 Individuals with MBL with mutated drivers have a shorter time to first therapy in comparison with circumstances with no mutations. When CLL is set up, the growth